248 related articles for article (PubMed ID: 26622536)
1. Clinical benefits of metformin in gynecologic oncology.
Imai A; Ichigo S; Matsunami K; Takagi H; Yasuda K
Oncol Lett; 2015 Aug; 10(2):577-582. PubMed ID: 26622536
[TBL] [Abstract][Full Text] [Related]
2. Molecular and Cellular Mechanisms of Metformin in Cervical Cancer.
Chen YH; Wang PH; Chen PN; Yang SF; Hsiao YH
Cancers (Basel); 2021 May; 13(11):. PubMed ID: 34067321
[TBL] [Abstract][Full Text] [Related]
3. Oral antidiabetic agents: current role in type 2 diabetes mellitus.
Krentz AJ; Bailey CJ
Drugs; 2005; 65(3):385-411. PubMed ID: 15669880
[TBL] [Abstract][Full Text] [Related]
4. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
Plosker GL; Figgitt DP
Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
[TBL] [Abstract][Full Text] [Related]
5. Metformin: A candidate for the treatment of gynecological tumors based on drug repositioning.
Irie H; Banno K; Yanokura M; Iida M; Adachi M; Nakamura K; Umene K; Nogami Y; Masuda K; Kobayashi Y; Tominaga E; Aoki D
Oncol Lett; 2016 Feb; 11(2):1287-1293. PubMed ID: 26893732
[TBL] [Abstract][Full Text] [Related]
6. [Metformin--new treatment strategies for gynecologic neoplasms].
Milewicz T; Kiałka M; Mrozińska S; Ociepka A; Krzysiek J
Przegl Lek; 2013; 70(2):81-4. PubMed ID: 23879009
[TBL] [Abstract][Full Text] [Related]
7. Metformin and gynecologic cancers.
Stine JE; Bae-Jump V
Obstet Gynecol Surv; 2014 Aug; 69(8):477-89. PubMed ID: 25144611
[TBL] [Abstract][Full Text] [Related]
8. Metformin: A Narrative Review of Its Potential Benefits for Cardiovascular Disease, Cancer and Dementia.
Top WMC; Kooy A; Stehouwer CDA
Pharmaceuticals (Basel); 2022 Mar; 15(3):. PubMed ID: 35337110
[TBL] [Abstract][Full Text] [Related]
9. Old drug, new trick: repurposing metformin for gynecologic cancers?
Febbraro T; Lengyel E; Romero IL
Gynecol Oncol; 2014 Dec; 135(3):614-21. PubMed ID: 25455733
[TBL] [Abstract][Full Text] [Related]
10. [Molecular action of insulin-sensitizing agents].
Kacalska O; Krzyczkowska-Sendrakowska M; Milewicz T; Zabińska-Popiela M; Bereza T; Krzysiek-Maczka G; Krzysiek J
Endokrynol Pol; 2005; 56(3):308-13. PubMed ID: 16350724
[TBL] [Abstract][Full Text] [Related]
11. Metformin as a Therapeutic Target in Endometrial Cancers.
Lee TY; Martinez-Outschoorn UE; Schilder RJ; Kim CH; Richard SD; Rosenblum NG; Johnson JM
Front Oncol; 2018; 8():341. PubMed ID: 30211120
[TBL] [Abstract][Full Text] [Related]
12. What every dentist should know about metformin, diabetes, and cancer.
Frykenberg MR; Schneider A; Bashirelahi N
Gen Dent; 2015; 63(5):70-2. PubMed ID: 26325646
[TBL] [Abstract][Full Text] [Related]
13. Metformin. A review of its pharmacological properties and therapeutic use in non-insulin-dependent diabetes mellitus.
Dunn CJ; Peters DH
Drugs; 1995 May; 49(5):721-49. PubMed ID: 7601013
[TBL] [Abstract][Full Text] [Related]
14. Metformin: a rising star to fight the epithelial mesenchymal transition in oncology.
Barrière G; Tartary M; Rigaud M
Anticancer Agents Med Chem; 2013 Feb; 13(2):333-40. PubMed ID: 22721394
[TBL] [Abstract][Full Text] [Related]
15. Diabetes mellitus and gynecologic cancer: molecular mechanisms, epidemiological, clinical and prognostic perspectives.
Vrachnis N; Iavazzo C; Iliodromiti Z; Sifakis S; Alexandrou A; Siristatidis C; Grigoriadis C; Botsis D; Creatsas G
Arch Gynecol Obstet; 2016 Feb; 293(2):239-46. PubMed ID: 26338721
[TBL] [Abstract][Full Text] [Related]
16. Cause-specific mortality in endometrioid endometrial cancer patients with type 2 diabetes using metformin or other types of antidiabetic medication.
Arima R; Hautakoski A; Marttila M; Arffman M; Sund R; Ilanne-Parikka P; Kangaskokko J; Hinkula M; Puistola U; Läärä E
Gynecol Oncol; 2017 Dec; 147(3):678-683. PubMed ID: 29054569
[TBL] [Abstract][Full Text] [Related]
17. [Metformin, an antidiabetic molecule with anti-cancer properties].
Beck E; Scheen AJ
Rev Med Liege; 2013 Sep; 68(9):444-9. PubMed ID: 24180199
[TBL] [Abstract][Full Text] [Related]
18. Metformin: risk-benefit profile with a focus on cancer.
Provinciali N; Lazzeroni M; Cazzaniga M; Gorlero F; Dunn BK; DeCensi A
Expert Opin Drug Saf; 2015 Oct; 14(10):1573-85. PubMed ID: 26359221
[TBL] [Abstract][Full Text] [Related]
19. Antidiabetic Medications and the Risk of Endometrial Cancer in Patients.
Tian J; Liang Y; Qu P
Gynecol Obstet Invest; 2019; 84(5):455-462. PubMed ID: 30808843
[TBL] [Abstract][Full Text] [Related]
20. Metformin for Prevention and Treatment of Colon Cancer: A Reappraisal of Experimental and Clinical Data.
Anisimov VN
Curr Drug Targets; 2016; 17(4):439-46. PubMed ID: 25738299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
